These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21512525)

  • 1. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of induced pluripotent stem cells in drug development.
    Inoue H; Yamanaka S
    Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human induced pluripotent stem cells: the past, present, and future.
    Hussein SM; Nagy K; Nagy A
    Clin Pharmacol Ther; 2011 May; 89(5):741-5. PubMed ID: 21430659
    [No Abstract]   [Full Text] [Related]  

  • 9. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells in research and therapy.
    Teoh HK; Cheong SK
    Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New era of regenerative medicine for cardiovascular diseases.
    Tse HF
    Thromb Haemost; 2010 Jul; 104(1):4-5. PubMed ID: 20539908
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges.
    Nirmalanandhan VS; Sittampalam GS
    J Biomol Screen; 2009 Aug; 14(7):755-68. PubMed ID: 19675315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine?
    Ensenat-Waser R; Pellicer A; Simon C
    Fertil Steril; 2009 Apr; 91(4):971-4. PubMed ID: 19200985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.